XILIUXI LIU11903LIU, XIInstructorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson17360482Ma Y, Fiering S, Black C, Liu X, Yuan Z, Memoli VA, Robbins DJ, Bentley HA, Tsongalis GJ, Demidenko E, Freemantle SJ, Dmitrovsky EProceedings of the National Academy of Sciences of the United States of AmericaTransgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A. 2007 Mar 06; 104(10):4089-94.Proc Natl Acad Sci U S A2007-02-27T00:00:002007Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas.18483313Liby K, Black CC, Royce DB, Williams CR, Risingsong R, Yore MM, Liu X, Honda T, Gribble GW, Lamph WW, Sporn TA, Dmitrovsky E, Sporn MBMolecular cancer therapeuticsThe rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis. Mol Cancer Ther. 2008 May; 7(5):1251-7.Mol Cancer Ther2008-05-01T00:00:002008The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis.Experimental TherapeuticsGynecological Oncology & Reproductive MedicineThoracic Head & Neck Medical OncologyTranslational Molecular PathologyMD AndersonJONATHAN MKURIEJONATHAN M KURIE8485KURIE, JONATHAN MProfessorJOHN VICTORHEYMACHJOHN VICTOR HEYMACH9280HEYMACH, JOHN VICTORProfessorETHANDMITROVSKYETHAN DMITROVSKY9907DMITROVSKY, ETHANProfessorGEORGE ACALINGEORGE A CALIN9408CALIN, GEORGE AProfessorANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessorIGNACIO IVANWISTUBAIGNACIO IVAN WISTUBA9098WISTUBA, IGNACIO IVANProfessor17868090Freemantle SJ, Liu X, Feng Q, Galimberti F, Blumen S, Sekula D, Kitareewan S, Dragnev KH, Dmitrovsky EJournal of cellular biochemistryCyclin degradation for cancer therapy and chemoprevention. J Cell Biochem. 2007 Nov 01; 102(4):869-77.J Cell Biochem2007-11-01T00:00:002007Cyclin degradation for cancer therapy and chemoprevention.19074853Feng Q, Sekula D, Guo Y, Liu X, Black CC, Galimberti F, Shah SJ, Sempere LF, Memoli V, Andersen JB, Hassel BA, Dragnev K, Dmitrovsky EMolecular cancer therapeuticsUBE1L causes lung cancer growth suppression by targeting cyclin D1. Mol Cancer Ther. 2008 Dec; 7(12):3780-8.Mol Cancer Ther2008-12-01T00:00:002008UBE1L causes lung cancer growth suppression by targeting cyclin D1.19618089Sempere LF, Liu X, Dmitrovsky ETheScientificWorldJournalTumor-suppressive microRNAs in Lung cancer: diagnostic and therapeutic opportunities. ScientificWorldJournal. 2009 Jul 13; 9:626-8.ScientificWorldJournal2009-07-13T00:00:002009Tumor-suppressive microRNAs in Lung cancer: diagnostic and therapeutic opportunities.21636548Dragnev KH, Ma T, Cyrus J, Galimberti F, Memoli V, Busch AM, Tsongalis GJ, Seltzer M, Johnstone D, Erkmen CP, Nugent W, Rigas JR, Liu X, Freemantle SJ, Kurie JM, Waxman S, Dmitrovsky ECancer prevention research (Philadelphia, Pa.)Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models. Cancer Prev Res (Phila). 2011 Jun; 4(6):818-28.Cancer Prev Res (Phila)2011-06-01T00:00:002011Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models.19228723Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, Dragnev KH, Ma Y, Fiering S, Memoli V, Li H, DiRenzo J, Korc M, Cole CN, Bak M, Kauppinen S, Dmitrovsky EClinical cancer research : an official journal of the American Association for Cancer ResearchUncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer Res. 2009 Feb 15; 15(4):1177-83.Clin Cancer Res2009-02-15T00:00:002009Uncovering growth-suppressive MicroRNAs in lung cancer.20237410Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, Kauppinen S, Dmitrovsky EThe Journal of clinical investigationMicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest. 2010 Apr; 120(4):1298-309.J Clin Invest2010-03-08T00:00:002010MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.20935222Guo Y, Dolinko AV, Chinyengetere F, Stanton B, Bomberger JM, Demidenko E, Zhou DC, Gallagher R, Ma T, Galimberti F, Liu X, Sekula D, Freemantle S, Dmitrovsky ECancer researchBlockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARa and inhibits the growth of acute promyelocytic leukemia. Cancer Res. 2010 Dec 01; 70(23):9875-85.Cancer Res2010-10-08T00:00:002010Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARa and inhibits the growth of acute promyelocytic leukemia.21420030Liu X, Sempere LF, Guo Y, Korc M, Kauppinen S, Freemantle SJ, Dmitrovsky ETranslational research : the journal of laboratory and clinical medicineInvolvement of microRNAs in lung cancer biology and therapy. Transl Res. 2011 Apr; 157(4):200-8.Transl Res2011-02-04T00:00:002011Involvement of microRNAs in lung cancer biology and therapy.20028770Galimberti F, Thompson SL, Liu X, Li H, Memoli V, Green SR, DiRenzo J, Greninger P, Sharma SV, Settleman J, Compton DA, Dmitrovsky EClinical cancer research : an official journal of the American Association for Cancer ResearchTargeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastrophe. Clin Cancer Res. 2010 Jan 01; 16(1):109-20.Clin Cancer Res2009-12-22T00:00:002009Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastrophe.74Professor54Instructor1515 Holcombe BlvdHouston77030-4009TX0.4559330.0030731885research areas1.778490.02569432coauthor of17.86191.6499560similar to1115selected publicationsAuthorship 3728924Authorship 37289313Authorship 3728943Authorship 3728951Authorship 3728962Authorship 3728977Authorship 37289811Authorship 3729011Authorship 3729021Authorship 3729994Authorship 3730002Authorship 846590Authorship 852557Authorship 853524Authorship 863318OncotargetThe ISG15-specific protease USP18 regulates stability of PTEN. Oncotarget. 8:3-14.The ISG15-specific protease USP18 regulates stability of PTENMolecular Cancer TherapeuticsDinaciclib induces anaphase catastrophe in lung cancer cells via inhibition of cyclin-dependent kinases 1 and 2. Molecular Cancer Therapeutics. 15:2758-2766.Dinaciclib induces anaphase catastrophe in lung cancer cells via inhibition of cyclin-dependent kinases 1 and 2Molecular Cancer TherapeuticsThe myb-p300 interaction is a novel molecular pharmacologic target. Molecular Cancer Therapeutics. 14:1273-1275.The myb-p300 interaction is a novel molecular pharmacologic targetCancer ResearchGOS2 suppresses oncogenic transformation by repressing a MYC-regulated transcriptional program. Cancer Research. 76:1204-1213.GOS2 suppresses oncogenic transformation by repressing a MYC-regulated transcriptional programD008175Disorders1353114820.199024Lung NeoplasmsD019938Chemicals & Drugs3095750.817076Cyclin D1D019927Chemicals & Drugs1082670.828729Cyclin ED035683Chemicals & Drugs75129430.373553MicroRNAsD025521Chemicals & Drugs64718230.547934Tumor Suppressor Proteinstrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1InstructorInstructor